Sm. Mcallister et al., DO INTERACTIONS WITH PHOSPHOLIPIDS CONTRIBUTE TO THE PROLONGED RETENTION OF POLYPEPTIDES WITHIN THE LUNG, Advanced drug delivery reviews, 19(1), 1996, pp. 89-110
Several amphipathic or hydrophobic polypeptides exhibited prolonged re
tention in the lung following pulmonary administrations. The physicoch
emical basis for prolonged retention remains uncertain but may be rela
ted to hydrophobic and electrostatic interactions between the polypept
ides and the phospholipids of lung tissues. The pulmonary absorption c
haracteristics of detirelix, polymyxin B, and cyclosporin A were revie
wed in relation to their interactions with phospholipids. Phospholipid
interactions were evaluated qualitatively by comparison of the effici
encies of polypeptides' incorporation into liposomes, and by a quantit
ative comparison of the polypeptide affinities for immobilized artific
ial membranes (IAM). Detirelix and cyclosporin A exhibited prolonged p
ulmonary retention compared with polymyxin B. Those observations corre
lated with the polypeptides' liposomal incorporation efficiencies and
IAM affinities. The duration of absorption of all three polypeptides w
as further extended following pulmonary administration of their liposo
mal formulations. A fourth polypeptide, lipopeptide L-693,989, was ide
ntified as possessing the structural hydrophobicity sufficient to inte
ract strongly with phospholipid bilayers: a possible explanation for i
ts prolonged pulmonary retention.